{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:26:40Z","timestamp":1790980000278,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1124\/jpet.107.120709","type":"journal-article","created":{"date-parts":[[2007,4,4]],"date-time":"2007-04-04T03:57:25Z","timestamp":1175659045000},"page":"214-221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["Pharmacological Effects of Ephedrine Alkaloids on Human \u03b11- and \u03b12-Adrenergic Receptor Subtypes"],"prefix":"10.1016","volume":"322","author":[{"given":"Guoyi","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supriya A.","family":"Bavadekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolande M.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpa G.","family":"Lalchandani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rangaswamy","family":"Nagmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian T.","family":"Schaneberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikhlas A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis R.","family":"Feller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.107.120709_bib1","doi-asserted-by":"crossref","unstructured":"Arch JR, Ainsworth AT, Cawthorne MA, Piercy V, Sennittt MV, Thody VE, Wilson C, and Wilson S (1984) Atypical \u03b2-adrenoceptor on brown adipocytes as target for anti-obesity drugs. Nature 309: 163\u2013165.","DOI":"10.1038\/309163a0"},{"key":"10.1124\/jpet.107.120709_bib2","doi-asserted-by":"crossref","unstructured":"Cheng Y and Prusoff WH (1973) Relationship between the inhibition constant (Ki) and the concentration of the inhibitor which causes 50% inhibition (IC50) of an enzymatic reaction. Biochemical Pharmacol 22: 3099\u20133108.","DOI":"10.1016\/0006-2952(73)90196-2"},{"key":"10.1124\/jpet.107.120709_bib3","doi-asserted-by":"crossref","unstructured":"Chua SS and Benrimoj SI (1988) Non-prescription sympathomimetic agents and hypertension. Med Toxicol Adverse Drug Exp 3: 387\u2013414.","DOI":"10.1007\/BF03259892"},{"key":"10.1124\/jpet.107.120709_bib4","doi-asserted-by":"crossref","unstructured":"Gether U, Lin S, and Kobilka BK (1995) Fluorescent labeling of purified \u03b22 adrenergic receptor: evidence for ligand-specific conformational changes. J Biol Chem 270: 28268\u201328275.","DOI":"10.1074\/jbc.270.47.28268"},{"key":"10.1124\/jpet.107.120709_bib5","unstructured":"Griffith RK and Johnson EA (1995) Adrenergic drugs, in Principles of Medicinal chemistry (Foye WO, Lemke TL and Williams DA eds) pp 345\u2013365, Williams & Wilkins, Baltimore."},{"key":"10.1124\/jpet.107.120709_bib6","doi-asserted-by":"crossref","unstructured":"Haller CA and Benowitz NL (2000) Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med 343: 1833\u20131838.","DOI":"10.1056\/NEJM200012213432502"},{"key":"10.1124\/jpet.107.120709_bib7","unstructured":"Hoffman BB (2001) Catecholamines, sympathomimetic drugs and adrenergic receptor antagonists, in Goodman and Gilman\u2019s Pharmacological Basis of Therapeutics (Hardman JG and Limbird LE eds) p. 237, McGraw Hill, New York."},{"key":"10.1124\/jpet.107.120709_bib8","doi-asserted-by":"crossref","unstructured":"Josefson D (1996) Herbal stimulant causes US deaths. BMJ 312: 1441.","DOI":"10.1136\/bmj.312.7044.1441"},{"key":"10.1124\/jpet.107.120709_bib9","doi-asserted-by":"crossref","unstructured":"Kalix P (1991). The pharmacology of psychoactive alkaloids from ephedra and catha. J Ethnopharmacol 32: 201\u2013208.","DOI":"10.1016\/0378-8741(91)90119-X"},{"key":"10.1124\/jpet.107.120709_bib10","doi-asserted-by":"crossref","unstructured":"Kawasuji T, Koike K, and Saito H (1996) Chronotropic effects of optical isomers of ephedrine and methylephedrine in the isolated rat right atria and in vitro assessment of direct and indirect actions on \u03b21-adrenoceptors. Biol Pharm Bull 19: 1423\u20131428.","DOI":"10.1248\/bpb.19.1423"},{"key":"10.1124\/jpet.107.120709_bib11","doi-asserted-by":"crossref","unstructured":"Lalchandani SG, Lei L, Zhang W, Suin MM, Moore BM, Liggett SB, Miller DD, and Feller DR (2002) Yohimbine dimmers exhibiting selectivity for the human \u03b12c-adrenoceptor subtype. J Pharmacol Exp Ther 303: 979\u2013984.","DOI":"10.1124\/jpet.102.039057"},{"key":"10.1124\/jpet.107.120709_bib12","doi-asserted-by":"crossref","unstructured":"Lapidus JB, Tye A, and Patil PN (1967) Steric aspects of adrenergic drugs. VII. Certain pharmacological actions of d-(\u2013)-pseudoephedrine. J Pharm Sci 56: 1125\u20131130.","DOI":"10.1002\/jps.2600560917"},{"key":"10.1124\/jpet.107.120709_bib13","doi-asserted-by":"crossref","unstructured":"Lee OS, Bescak G, Miller DD, and Feller DR (1974) Influence of substituted phenethylamines on lipolysis, in vitro. III. Stereoselectivity. J Pharmacol Exp Ther 190: 249\u2013259.","DOI":"10.1016\/S0022-3565(25)29916-5"},{"key":"10.1124\/jpet.107.120709_bib14","doi-asserted-by":"crossref","unstructured":"Liles JT, Dabisch PA, Hude KE, Pradhan L, Varner KJ, Porter JR, Hicks AR, Corll C, Baber SR, and Kadowitz PJ (2006) Pressor responses to ephedrine are mediated by a direct mechanism in the rat. J Pharmacol Exp Ther 316: 95\u2013105.","DOI":"10.1124\/jpet.105.090035"},{"key":"10.1124\/jpet.107.120709_bib15","unstructured":"Liu YL, Toubro S, Astrup A, and Stock MJ (1995) Contribution of \u03b23-adrenergic activation to ephedrine-induced thermogenesis in humans. Int J Obes Relat Metab Disord 19: 678\u2013685."},{"key":"10.1124\/jpet.107.120709_bib16","unstructured":"Ma G, Bavadekar SA, Davis MY, Lalchandani SG, Nagmani R, Khan I, and Feller DR (2004). Pharmacological effects of ephedra alkaloids on human alpha-adrenergic receptor subtypes, in Proceedings of the 25th Southeastern Pharmacology Society Meeting; 2004 November 4\u20135; The University of Mississippi, University, MS. American Society for Pharmacology and Experimental Therapeutics, Bethesda, MD."},{"key":"10.1124\/jpet.107.120709_bib17","doi-asserted-by":"crossref","unstructured":"Patil PN (1968) Steric aspects of adrenergic drugs. VIII. Optical isomers of beta adrenergic receptor antagonists. J Pharmacol Exp Ther 160: 308\u2013314.","DOI":"10.1016\/S0022-3565(25)27925-3"},{"key":"10.1124\/jpet.107.120709_bib18","doi-asserted-by":"crossref","unstructured":"Patil PN, Lapidus JB, Molinari S, and Tye A (1967) Steric aspects of adrenergic drugs. IV. Antagonism of norepinephrine effects by ephedrine isomers on the isolated rabbit ileum. J Pharm Sci 56: 287\u2013288.","DOI":"10.1002\/jps.2600560233"},{"key":"10.1124\/jpet.107.120709_bib19","doi-asserted-by":"crossref","unstructured":"Patil PN, Tye A, and Lapidus JB (1965) A pharmacological study of the ephedrine isomers. J Pharmacol Exp Ther 148: 158\u2013168.","DOI":"10.1016\/S0022-3565(25)27031-8"},{"key":"10.1124\/jpet.107.120709_bib20","doi-asserted-by":"crossref","unstructured":"Rothman RB, Vu N, Partilla JS, Roth BL, Hufeisen SJ, Compton-Toth BA, Birkes J, Young R, and Glennon RA (2003) In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective action as norepinephrine transporter substrates. J Pharmacol Exp Ther 307: 138\u2013145.","DOI":"10.1124\/jpet.103.053975"},{"key":"10.1124\/jpet.107.120709_bib21","doi-asserted-by":"crossref","unstructured":"Stratowa C, Machat H, Burger E, Himmler A, Schafer R, Spevak W, Weyer U, Wiche-Castanon M, and Czernilofsky AP (1995) Functional characterization of the human neurokinin receptors NK1, NK2, and NK3 based on a cellular assay system. J Recept Res 15: 617\u2013630.","DOI":"10.3109\/10799899509045244"},{"key":"10.1124\/jpet.107.120709_bib22","doi-asserted-by":"crossref","unstructured":"Trendelenburg U (1963) Supersensitivity and subsensitivity to sympathomimetic amines. Pharmacol Rev 15: 225\u2013276.","DOI":"10.1016\/S0031-6997(25)07025-5"},{"key":"10.1124\/jpet.107.120709_bib23","doi-asserted-by":"crossref","unstructured":"Trendelenburg U, Delasierra BG, and Muskus A (1963) Modification by reserpine of the response of atrial pacemaker to sympathomimetic amines. J Pharmacol Exp Ther 141: 301\u2013309.","DOI":"10.1016\/S0022-3565(25)26615-0"},{"key":"10.1124\/jpet.107.120709_bib24","doi-asserted-by":"crossref","unstructured":"Tye A, Baldeserger R, LaPidus JB, and Patil PN (1967) Steric aspects of adrenergic drugs. VI. Beta adrenergic effects of ephedrine isomers. J Pharmacol Exp Ther 157: 56\u2013362.","DOI":"10.1016\/S0022-3565(25)27714-X"},{"key":"10.1124\/jpet.107.120709_bib25","doi-asserted-by":"crossref","unstructured":"Vansal SS and Feller DR (1999). Direct effects of ephedrine isomers on human beta-adrenergic receptor subtypes. Biochem Pharmacol 58: 807\u2013810.","DOI":"10.1016\/S0006-2952(99)00152-5"},{"key":"10.1124\/jpet.107.120709_bib26","doi-asserted-by":"crossref","unstructured":"Waldeck B and Widmark E (1985) The interaction of ephedrine with beta-adrenoceptors in tracheal, cardiac and skeletal muscles. Clin Exp Pharmacol Physiol 12: 439\u2013442.","DOI":"10.1111\/j.1440-1681.1985.tb00891.x"},{"key":"10.1124\/jpet.107.120709_bib27","doi-asserted-by":"crossref","unstructured":"Waugh DJ, Zhao MM, Zuscik MJ, and Perez DM (2000) Novel aromatic residues in transmembrane domains IV and V involved in agonist binding at alpha1a-adrenergic receptors. J Biol Chem 275: 11698\u201311705.","DOI":"10.1074\/jbc.275.16.11698"},{"key":"10.1124\/jpet.107.120709_bib28","doi-asserted-by":"crossref","unstructured":"Wellman PJ, Miller DK, and Ho DH (2003) Noradrenergic modulation of ephedrine-induced hypophagia. Synapse 48: 18\u201324.","DOI":"10.1002\/syn.10182"},{"key":"10.1124\/jpet.107.120709_bib29","doi-asserted-by":"crossref","unstructured":"White LM, Gardner SF, Curley BJ, Narx MA, Wang P, and Estes M (1997) Pharmacokinetics and cardiovascular effects of Ma Huang (Ephedra sinica) in normotensive adults. J Clin Pharmacol 37: 116\u2013122.","DOI":"10.1002\/j.1552-4604.1997.tb04769.x"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524339370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524339370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.107.120709","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T22:18:57Z","timestamp":1740003537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524339370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S0022356524339370"],"URL":"https:\/\/doi.org\/10.1124\/jpet.107.120709","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological Effects of Ephedrine Alkaloids on Human \u03b11- and \u03b12-Adrenergic Receptor Subtypes","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.107.120709","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2007 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}